CV-4-26 is an TEAD inhibitor as Potential Antiliver Cancer Agent. CV-4-26 exhibited great antitumor activity in HCC and HB cell lines in vitro, xenografted human HCC, and murine HB in vivo. These outcomes signify the potential of a highly promising therapeutic candidate for addressing a subset of HCC and HB cancers
MedKoo Cat#: 127828
Name: CV-4-26
CAS#: N/A
Chemical Formula: C18H12Cl2F3NO2
Exact Mass: 401.0197
Molecular Weight: 402.19
Elemental Analysis: C, 53.75; H, 3.01; Cl, 17.63; F, 14.17; N, 3.48; O, 7.96
The following data is based on the product molecular weight 402.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |